Barclays’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23M Buy
583,266
+229,329
+65% +$9.06M 0.01% 760
2025
Q1
$10.7M Sell
353,937
-242,135
-41% -$7.31M ﹤0.01% 980
2024
Q4
$20.8M Sell
596,072
-40,960
-6% -$1.43M 0.01% 763
2024
Q3
$25.5M Buy
637,032
+21,358
+3% +$856K 0.01% 671
2024
Q2
$29.3M Buy
615,674
+38,287
+7% +$1.82M 0.01% 616
2024
Q1
$25M Sell
577,387
-67,121
-10% -$2.91M 0.01% 682
2023
Q4
$32.6M Buy
644,508
+4,955
+0.8% +$251K 0.01% 621
2023
Q3
$29M Buy
639,553
+97,321
+18% +$4.41M 0.02% 598
2023
Q2
$22.2M Buy
542,232
+83,415
+18% +$3.42M 0.01% 643
2023
Q1
$16.4M Sell
458,817
-48,494
-10% -$1.73M 0.01% 652
2022
Q4
$19.2M Buy
507,311
+2,823
+0.6% +$107K 0.01% 659
2022
Q3
$22.3M Buy
504,488
+149,909
+42% +$6.63M 0.02% 553
2022
Q2
$13.1M Buy
354,579
+38,229
+12% +$1.42M 0.01% 732
2022
Q1
$11.7M Sell
316,350
-13,588
-4% -$503K 0.01% 820
2021
Q4
$10M Sell
329,938
-353
-0.1% -$10.7K ﹤0.01% 893
2021
Q3
$11.1M Sell
330,291
-33,705
-9% -$1.13M 0.01% 884
2021
Q2
$14.5M Buy
363,996
+265,225
+269% +$10.6M 0.01% 790
2021
Q1
$4.44M Buy
98,771
+29,106
+42% +$1.31M ﹤0.01% 1275
2020
Q4
$3.94M Sell
69,665
-6,182
-8% -$350K ﹤0.01% 1138
2020
Q3
$3.6M Sell
75,847
-3,954
-5% -$188K ﹤0.01% 1145
2020
Q2
$4.71M Buy
79,801
+16,979
+27% +$1M ﹤0.01% 965
2020
Q1
$2.97M Sell
62,822
-32,258
-34% -$1.53M ﹤0.01% 1122
2019
Q4
$5.74M Buy
95,080
+40,921
+76% +$2.47M ﹤0.01% 1126
2019
Q3
$3.24M Sell
54,159
-204,634
-79% -$12.3M ﹤0.01% 1376
2019
Q2
$16.6M Buy
258,793
+140,885
+119% +$9.06M 0.01% 653
2019
Q1
$9.57M Buy
117,908
+55,351
+88% +$4.49M 0.01% 769
2018
Q4
$3.38M Sell
62,557
-12,479
-17% -$674K ﹤0.01% 1091
2018
Q3
$3.87M Buy
75,036
+61,681
+462% +$3.18M ﹤0.01% 1239
2018
Q2
$556K Sell
13,355
-51,490
-79% -$2.14M ﹤0.01% 2204
2018
Q1
$2.86M Buy
64,845
+51,577
+389% +$2.27M ﹤0.01% 1176
2017
Q4
$667K Sell
13,268
-29,739
-69% -$1.5M ﹤0.01% 1893
2017
Q3
$2.18M Buy
43,007
+30,256
+237% +$1.53M ﹤0.01% 1168
2017
Q2
$649K Sell
12,751
-61,439
-83% -$3.13M ﹤0.01% 1784
2017
Q1
$2.98M Buy
74,190
+28,562
+63% +$1.15M ﹤0.01% 991
2016
Q4
$2.18M Buy
45,628
+11,077
+32% +$530K ﹤0.01% 1109
2016
Q3
$1.27M Sell
34,551
-106,115
-75% -$3.89M ﹤0.01% 1293
2016
Q2
$3.28M Buy
140,666
+78,330
+126% +$1.82M ﹤0.01% 888
2016
Q1
$2.49M Sell
62,336
-6,659
-10% -$266K ﹤0.01% 976
2015
Q4
$4.21M Sell
68,995
-29,766
-30% -$1.82M 0.01% 766
2015
Q3
$3.95M Buy
98,761
+17,820
+22% +$713K ﹤0.01% 783
2015
Q2
$4.62M Sell
80,941
-21,998
-21% -$1.25M 0.01% 841
2015
Q1
$6.49M Buy
102,939
+22,265
+28% +$1.4M 0.01% 791
2014
Q4
$4.92M Sell
80,674
-33,278
-29% -$2.03M ﹤0.01% 928
2014
Q3
$4.33M Sell
113,952
-65,505
-37% -$2.49M ﹤0.01% 1021
2014
Q2
$6.1M Buy
179,457
+81,525
+83% +$2.77M 0.01% 858
2014
Q1
$4.21M Buy
97,932
+2,991
+3% +$129K ﹤0.01% 1003
2013
Q4
$3.7M Buy
94,941
+38,869
+69% +$1.52M ﹤0.01% 1112
2013
Q3
$2.08M Buy
56,072
+21,400
+62% +$792K ﹤0.01% 1262
2013
Q2
$931K Buy
+34,672
New +$931K ﹤0.01% 1796